No profile data available.
CBD Life Sciences Inc. (CBDL) is an essential consumer products company in the marijuana product manufacturing industry, based in Scottsdale, United States, with about 3 full-time employees.
It reported revenue of $122,789 for fiscal year 2014, down 21.1% from fiscal year 2013, and net income of -$780,139. In Q3 2015 (the quarter ended September 30, 2015) revenue was $0. Its market capitalization was $1.22 million as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2014; market data as of October 8, 2026.
CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, coffee, wine, skincare line, tablets, and a line of pet products. CBD Life Sciences Inc.
CBD Life Sciences reported $122,789 in revenue for fiscal year 2014, down 21.1% from $155,553 in fiscal year 2013. In Q3 2015 revenue was $0.
$1.22 million as of October 8, 2026.
Listed companies of a similar size in the same industry (marijuana product manufacturing) include Agro Capital Management Corp. (ACMB), CBD of Denver Inc. (CBDD), Anything Technologies Media, Inc. (EXMT), Omid Holdings, Inc. (OMID).